NF-κB
SIRT1/Nrf2 signaling
Ulva pertusa
anti-inflammatory
antioxidant
apoptosis
inflammatory bowel disease (IBD)
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Jul 2022
25 Jul 2022
Historique:
received:
21
06
2022
revised:
11
07
2022
accepted:
22
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Inflammatory bowel diseases (IBD) including Crohn's disease (CD) and ulcerative colitis (UC) represent gastrointestinal (GI) disorders associated with varied responses to microbial and environmental agents. Natural compounds have been suggested as a valid approach to the management of various GI diseases, particularly the green alga
Identifiants
pubmed: 35893393
pii: jcm11154301
doi: 10.3390/jcm11154301
pmc: PMC9331369
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Mol Sci. 2021 Sep 28;22(19):
pubmed: 34638811
Mol Neurobiol. 2019 Jun;56(6):3937-3947
pubmed: 30229438
Biomed Res Int. 2018 May 9;2018:1290179
pubmed: 29854724
Biomedicines. 2020 Nov 20;8(11):
pubmed: 33233503
Nutrients. 2020 Mar 29;12(4):
pubmed: 32235316
J Pineal Res. 2006 Nov;41(4):363-73
pubmed: 17014694
Cells. 2021 Oct 14;10(10):
pubmed: 34685736
Immunopharmacol Immunotoxicol. 2022 Jun;44(3):373-386
pubmed: 35254187
J Gastroenterol. 2021 Aug;56(8):732-745
pubmed: 34148144
Antioxidants (Basel). 2022 Feb 17;11(2):
pubmed: 35204289
Sci Rep. 2017 Jan 17;7:40631
pubmed: 28094779
Gastroenterol Res Pract. 2014;2014:762191
pubmed: 25506359
Cells. 2019 Apr 30;8(5):
pubmed: 31052214
Pharmacol Res. 2021 Jan;163:105243
pubmed: 33080322
Phytother Res. 2014 Dec;28(12):1867-72
pubmed: 25219371
J Mol Med (Berl). 2020 Apr;98(4):595-612
pubmed: 32338310
Antioxidants (Basel). 2021 Mar 09;10(3):
pubmed: 33803138
Biochem Pharmacol. 2020 Oct;180:114153
pubmed: 32679126
Biomedicines. 2021 Sep 29;9(10):
pubmed: 34680471
J Med Food. 2021 Mar;24(3):236-247
pubmed: 33739884
Int J Biol Macromol. 2020 Aug 15;157:75-82
pubmed: 32344076
Innate Immun. 2020 Oct;26(7):609-617
pubmed: 32924710
Int J Mol Sci. 2021 Feb 17;22(4):
pubmed: 33671213
Mar Drugs. 2020 Sep 29;18(10):
pubmed: 33003577
Arch Med Res. 2021 Aug;52(6):595-602
pubmed: 33814208
Pharmaceutics. 2020 Sep 03;12(9):
pubmed: 32899177
Front Nutr. 2022 Apr 29;9:868657
pubmed: 35571944
Int Immunopharmacol. 2019 Aug;73:193-200
pubmed: 31103874
Int J Mol Sci. 2021 Aug 13;22(16):
pubmed: 34445417
J Am Coll Nutr. 2002 Dec;21(6):495-505
pubmed: 12480795
J Crohns Colitis. 2016 Apr;10(4):472-83
pubmed: 26690241
Saudi J Gastroenterol. 2016 Jan-Feb;22(1):3-17
pubmed: 26831601
Int J Mol Sci. 2020 Apr 24;21(8):
pubmed: 32344758
Gastroenterol Clin North Am. 2017 Dec;46(4):797-808
pubmed: 29173522
J Crohns Colitis. 2016 Oct 20;11(3):263-273
pubmed: 27797918
J Pharmacol Methods. 1985 Nov;14(3):157-67
pubmed: 2997548
Inflammopharmacology. 2019 Apr;27(2):349-359
pubmed: 29907915
Prim Care. 2017 Dec;44(4):673-692
pubmed: 29132528
Carbohydr Polym. 2021 Feb 15;254:117189
pubmed: 33357839
Toxicol Lett. 2019 Nov;316:109-118
pubmed: 31472180
Neurosci Lett. 2009 Apr 17;454(1):11-5
pubmed: 19429045
Pharmacol Res. 2003 Dec;48(6):543-9
pubmed: 14527817
Gastroenterology. 2021 Apr;160(5):1709-1724
pubmed: 33421512
Antioxidants (Basel). 2020 Oct 01;9(10):
pubmed: 33019631
Int J Biol Macromol. 2005 Dec 15;37(4):195-9
pubmed: 16310843
Neuropharmacology. 2020 Apr;166:107977
pubmed: 32004548
JAMA Pediatr. 2015 Nov;169(11):1053-60
pubmed: 26414706
Mediators Inflamm. 2018 Feb 15;2018:8430614
pubmed: 29670469